# Medalist Diversified, Inc.: financial statements, quarterly

MDRR · Nasdaq · CIK 1654595 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mdrr.md) · [Financials](/companies/mdrr/financials.md) · [Filings](/companies/mdrr/filings.md) · [Insiders](/companies/mdrr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mdrr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2.6](/filings/0001558370-24-015321.md) | [2.7 d](/filings/0001558370-25-001807.md) | [2.6](/filings/0001558370-25-006975.md) | [2.3](/filings/0001558370-25-010758.md) | [2.3](/filings/0001104659-25-107749.md) | [2.5 d](/filings/0001104659-26-022253.md) | [2.3](/filings/0001558370-25-006975.md) | [2.5](/filings/0001558370-25-010758.md) | [2.8](/filings/0001104659-25-107749.md) | [2.8 d](/filings/0001104659-26-022253.md) | [2.2](/filings/0001104659-26-060239.md) | [1.8](/filings/0001104659-26-095898.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(1.1)](/filings/0001558370-24-015321.md) | [0.5 d](/filings/0001558370-25-001807.md) | [2.8](/filings/0001558370-25-006975.md) | [0.2](/filings/0001558370-25-010758.md) | [0.3](/filings/0001104659-25-107749.md) | [0.4 d](/filings/0001104659-26-022253.md) | [(0.6)](/filings/0001104659-26-060239.md) | [0.2](/filings/0001104659-26-095898.md) | [0.4](/filings/0001104659-25-107749.md) | [0.5 d](/filings/0001104659-26-022253.md) | [12.3](/filings/0001104659-26-060239.md) | [(0.4)](/filings/0001104659-26-095898.md) |
| Interest expense | $m | [0.9](/filings/0001558370-24-015321.md) | [0.9 d](/filings/0001558370-25-001807.md) | [0.9](/filings/0001558370-25-006975.md) | [0.7](/filings/0001558370-25-010758.md) | [0.7](/filings/0001104659-25-107749.md) | [0.7 d](/filings/0001104659-26-022253.md) | [0.6](/filings/0001104659-26-060239.md) | [0.6](/filings/0001104659-26-095898.md) | [0.8](/filings/0001104659-25-107749.md) | [0.7 d](/filings/0001104659-26-022253.md) | [0.5](/filings/0001104659-26-060239.md) | [0.3](/filings/0001104659-26-095898.md) |
| Income tax | $m | not reported | not reported | not reported | [0.0](/filings/0001558370-25-010758.md) | [0.0](/filings/0001104659-25-107749.md) | [0.0 d](/filings/0001104659-26-022253.md) | not reported | not reported | not reported | not reported | [(2.1)](/filings/0001104659-26-060239.md) | [0.0](/filings/0001104659-26-095898.md) |
| Net income | $m | [(1.9)](/filings/0001558370-24-015321.md) | [(0.5) d](/filings/0001558370-25-005708.md) | [1.4](/filings/0001558370-25-006975.md) | [(0.5)](/filings/0001558370-25-010758.md) | [(0.5)](/filings/0001104659-25-107749.md) | [(0.3) d](/filings/0001104659-26-022253.md) | [(1.0)](/filings/0001104659-26-060239.md) | [(0.5)](/filings/0001104659-26-095898.md) | [(0.4)](/filings/0001104659-25-107749.md) | [(0.5) d](/filings/0001104659-26-022253.md) | [9.0](/filings/0001104659-26-060239.md) | [(0.4)](/filings/0001104659-26-095898.md) |
| Diluted EPS | $ per share | [(1.76)](/filings/0001558370-24-015321.md) | not reported | [1.21](/filings/0001558370-25-006975.md) | [(0.47)](/filings/0001558370-25-010758.md) | [(0.47)](/filings/0001104659-25-107749.md) | not reported | [(0.74)](/filings/0001104659-26-060239.md) | [(0.34)](/filings/0001104659-26-095898.md) | [(0.33)](/filings/0001104659-25-107749.md) | not reported | [4.85](/filings/0001104659-26-060239.md) | [(0.26)](/filings/0001104659-26-095898.md) |
| Basic EPS | $ per share | [(1.76)](/filings/0001558370-24-015321.md) | not reported | [1.22](/filings/0001558370-25-006975.md) | [(0.47)](/filings/0001558370-25-010758.md) | [(0.47)](/filings/0001104659-25-107749.md) | not reported | [(0.74)](/filings/0001104659-26-060239.md) | [(0.34)](/filings/0001104659-26-095898.md) | [(0.33)](/filings/0001104659-25-107749.md) | not reported | [7.01](/filings/0001104659-26-060239.md) | [(0.26)](/filings/0001104659-26-095898.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.0](/filings/0001558370-24-015321.md) | [2.2](/filings/0001558370-25-001807.md) | [3.6](/filings/0001558370-25-006975.md) | [3.8](/filings/0001558370-25-010758.md) | [3.1](/filings/0001104659-25-107749.md) | [4.8](/filings/0001104659-26-022253.md) | [2.7](/filings/0001104659-26-060239.md) | [2.0](/filings/0001104659-26-095898.md) | [1.9](/filings/0001104659-25-107749.md) | [2.6](/filings/0001104659-26-095898.md) | [8.6](/filings/0001104659-26-060239.md) | [6.4](/filings/0001104659-26-095898.md) |
| Total assets | $m | [84.4](/filings/0001558370-23-018846.md) | [82.7](/filings/0001558370-25-001807.md) | [76.0](/filings/0001558370-24-007624.md) | [75.2](/filings/0001558370-24-011749.md) | [74.6](/filings/0001558370-24-015321.md) | [75.1](/filings/0001104659-26-022253.md) | [78.2](/filings/0001558370-25-006975.md) | [77.7](/filings/0001558370-25-010758.md) | [92.1](/filings/0001104659-25-107749.md) | [77.7](/filings/0001104659-26-095898.md) | [68.9](/filings/0001104659-26-060239.md) | [57.8](/filings/0001104659-26-095898.md) |
| Total liabilities | $m | [70.2](/filings/0001558370-23-018846.md) | [69.0](/filings/0001558370-25-001807.md) | [58.3](/filings/0001558370-24-007624.md) | [58.2](/filings/0001558370-24-011749.md) | [58.1](/filings/0001558370-24-015321.md) | [54.1](/filings/0001104659-26-022253.md) | [52.4](/filings/0001558370-25-006975.md) | [52.3](/filings/0001558370-25-010758.md) | [67.1](/filings/0001104659-25-107749.md) | [53.6](/filings/0001104659-26-095898.md) | [29.0](/filings/0001104659-26-060239.md) | [20.5](/filings/0001104659-26-095898.md) |
| Long-term debt | $m | not reported | [60.4](/filings/0001558370-24-002614.md) | not reported | not reported | not reported | not reported | not reported | [49.6](/filings/0001558370-25-010758.md) | [63.6](/filings/0001104659-25-107749.md) | [51.4](/filings/0001104659-26-022253.md) | [26.7](/filings/0001104659-26-060239.md) | [19.1](/filings/0001104659-26-095898.md) |
| Short-term borrowings | $m | [1.0](/filings/0001558370-23-018846.md) | [1.0](/filings/0001558370-25-001807.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [12.8](/filings/0001558370-23-018846.md) | [12.3](/filings/0001558370-25-001807.md) | [13.7](/filings/0001558370-24-007624.md) | [13.2](/filings/0001558370-24-011749.md) | [12.6](/filings/0001558370-24-015321.md) | [15.0](/filings/0001104659-26-022253.md) | [14.0](/filings/0001558370-25-006975.md) | [13.4](/filings/0001558370-25-010758.md) | [10.4](/filings/0001104659-25-107749.md) | [9.4](/filings/0001104659-26-095898.md) | [22.3](/filings/0001104659-26-060239.md) | [24.0](/filings/0001104659-26-095898.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(447) d](/filings/0001558370-24-015321.md) | [(312) d](/filings/0001558370-25-001807.md) | [492](/filings/0001558370-25-006975.md) | [779 d](/filings/0001558370-25-010758.md) | [140 d](/filings/0001104659-25-107749.md) | [385 d](/filings/0001104659-26-022253.md) | [460](/filings/0001104659-26-060239.md) | [244 d](/filings/0001104659-26-095898.md) | [1,568 d](/filings/0001104659-25-107749.md) | [(741) d](/filings/0001104659-26-022253.md) | [(508)](/filings/0001104659-26-060239.md) | [321 d](/filings/0001104659-26-095898.md) |
| Dividends paid | $k | [0.0 d](/filings/0001558370-23-018846.md) | [9.0 d](/filings/0001558370-24-002614.md) | [511](/filings/0001558370-24-007624.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001104659-26-022253.md) | [107](/filings/0001104659-26-060239.md) | [34.2 d](/filings/0001104659-26-095898.md) | [0.0 d](/filings/0001104659-25-107749.md) | [0.0 d](/filings/0001104659-26-022253.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [2,180](/filings/0001558370-23-018846.md) | [2,220](/filings/0001558370-24-007624.md) | [1,110](/filings/0001558370-24-011749.md) | [1,109](/filings/0001558370-24-015321.md) | [1,124](/filings/0001558370-25-006975.md) | [1,118](/filings/0001558370-25-010758.md) | [1,116](/filings/0001104659-25-107749.md) | [1,357](/filings/0001104659-26-060239.md) | [1,353](/filings/0001104659-26-095898.md) | [1,213](/filings/0001104659-25-107749.md) | [1,848](/filings/0001104659-26-060239.md) | [1,593](/filings/0001104659-26-095898.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,628,500 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001104659-26-095898.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.